Short answer · Medically reviewed summary · Last updated: 2023-07-13
Olivopontocerebellar Atrophy (OPCA) is a rare neurodegenerative disorder characterized by the progressive degeneration of certain areas of the brain, including the cerebellum, pons, and inferior olivary nucleus. OPCA is classified into three main types: Type 1, Type 2, and Type 3, each with distinct genetic causes. The prevalence of OPCA varies depending on the specific type.
Olivopontocerebellar Atrophy (OPCA) is a rare neurodegenerative disorder characterized by the progressive degeneration of certain areas of the brain, including the cerebellum, pons, and inferior olivary nucleus. OPCA is classified into three main types: Type 1, Type 2, and Type 3, each with distinct genetic causes.
The prevalence of OPCA varies depending on the specific type. Type 1 OPCA, also known as Machado-Joseph disease, is the most common form and is more prevalent in certain populations, particularly those of Portuguese ancestry. It has an estimated prevalence of 1 in 20,000 to 1 in 40,000 individuals worldwide.
Type 2 OPCA, caused by mutations in the gene known as CACNA1A, is less common and has an estimated prevalence of 1 in 1 million individuals.
Type 3 OPCA, also referred to as sporadic OPCA, is the least common form and its prevalence is not well-established. It is believed to be extremely rare, affecting a very small percentage of the population.
Due to the rarity of OPCA, it is considered a rare disease. The symptoms of OPCA typically manifest in adulthood and progressively worsen over time, leading to various motor and non-motor impairments.
It is important to note that accurate prevalence figures may vary due to underdiagnosis, misdiagnosis, and limited data availability. If you suspect you or someone you know may have OPCA, it is crucial to consult with a healthcare professional for a proper diagnosis and appropriate management.